144 related articles for article (PubMed ID: 28971985)
1. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study.
Kamstrup PR; Nordestgaard BG
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):220-7. PubMed ID: 24622370
[TBL] [Abstract][Full Text] [Related]
3.
Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
Coassin S; Kronenberg F
Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
[TBL] [Abstract][Full Text] [Related]
6. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
[TBL] [Abstract][Full Text] [Related]
7. High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization Study.
Langsted A; Kamstrup PR; Nordestgaard BG
Clin Chem; 2017 Nov; 63(11):1714-1723. PubMed ID: 28877919
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.
Lanktree MB; Anand SS; Yusuf S; Hegele RA;
Circ Cardiovasc Genet; 2010 Feb; 3(1):39-46. PubMed ID: 20160194
[TBL] [Abstract][Full Text] [Related]
9. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.
Sticchi E; Magi A; Kamstrup PR; Marcucci R; Prisco D; Martinelli I; Mannucci PM; Abbate R; Giusti B
PLoS One; 2016; 11(2):e0149427. PubMed ID: 26900838
[TBL] [Abstract][Full Text] [Related]
11. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
[TBL] [Abstract][Full Text] [Related]
12. Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.
Schachtl-Riess JF; Kheirkhah A; Grüneis R; Di Maio S; Schoenherr S; Streiter G; Losso JL; Paulweber B; Eckardt KU; Köttgen A; Lamina C; Kronenberg F; Coassin S;
J Am Coll Cardiol; 2021 Aug; 78(5):437-449. PubMed ID: 34325833
[TBL] [Abstract][Full Text] [Related]
13. Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the "Montignoso Study".
Sereni A; Sticchi E; Gori AM; Magi A; Della Latta D; Volta A; Murri A; Jamagidze G; Chiappino D; Abbate R; Gensini GF; Marcucci R; Sofi F; Giusti B
Intern Emerg Med; 2020 Oct; 15(7):1239-1245. PubMed ID: 31993950
[TBL] [Abstract][Full Text] [Related]
14. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
[TBL] [Abstract][Full Text] [Related]
15. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive map of single-base polymorphisms in the hypervariable
Coassin S; Schönherr S; Weissensteiner H; Erhart G; Forer L; Losso JL; Lamina C; Haun M; Utermann G; Paulweber B; Specht G; Kronenberg F
J Lipid Res; 2019 Jan; 60(1):186-199. PubMed ID: 30413653
[TBL] [Abstract][Full Text] [Related]
19. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
Kamstrup PR; Nordestgaard BG
JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly.
Becker L; Cook PM; Wright TG; Koschinsky ML
J Biol Chem; 2004 Jan; 279(4):2679-88. PubMed ID: 14581473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
